HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.

Yoel A Fleites, Jorge Aguiar, Zurina Cinza,Monica Bequet, Elieser Marrero, Maritania Vizcaíno, Idelsis Esquivel, Marisol Diaz,Adriana Sin-Mayor,Maura Garcia, Sara M Martinez, Abrahan Beato, Ana G Galarraga,Yssel Mendoza-Mari,Iris Valdés, Gerardo García,Gilda Lemos, Isabel González,Camila Canaán-Haden, Nelvis Figueroa, Rachel Oquendo,Sheikh Mf Akbar,Mamun A Mahtab,Mohammad H Uddin,Gerardo E Guillén,Verena L Muzio,Eduardo Pentón,Julio C Aguilar

Euroasian journal of hepato-gastroenterology（2021）

引用 4|浏览5

暂无评分

摘要

Fleites YA, Aguiar J, Cinza Z, HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis. Euroasian J Hepato-Gastroenterol 2021;11(2):59-70.

查看译文

关键词

Immunity,Innate,Postexposure,Prophylaxis,SARS-CoV-2,Therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要